Grading of Atrophic Gastritis is Useful for Risk Stratification in Endoscopic Screening for Gastric Cancer
In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings. First, subjects who underwent both cancer screening and...
Saved in:
Published in | The American journal of gastroenterology Vol. 114; no. 1; pp. 71 - 79 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
01.01.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0002-9270 1572-0241 1572-0241 |
DOI | 10.1038/s41395-018-0259-5 |
Cover
Abstract | In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings.
First, subjects who underwent both cancer screening and medical examination from 2009 to 2015 and underwent cancer screening once more by 2016 were studied. Data such as the lipid profile and history of smoking obtained during the medical examination, and the grade of atrophy and presence of peptic ulcers were studied using multivariate analysis. Next, subjects who underwent cancer screening twice or more between 2009 and 2015 with or without medical examinations were studied to analyze any correlation between the grade of atrophy and cancer occurrence using univariate analysis. In both studies, the status of Helicobacter pylori (HP) infection was determined.
In the multivariate analysis, 9378 subjects were included. Aging, advanced atrophy, presence of ulcers, and uric acid levels were identified as risk factors. Among subjects who underwent successful HP eradication therapy, advanced atrophy and aging were observed to be crucial risk factors. In the univariate analysis, there were 12,941 subjects. Gastric cancer occurred more frequently in the more severe atrophy group (P < 0.001). The annual rate of cancer occurrence in the most severe atrophy group was 0.31%, which was approximately thrice as that in the less atrophy group.
Risk stratification was possible based on endoscopic examination alone. The interval should be set depending on each case. |
---|---|
AbstractList | OBJECTIVES:In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings.METHODS:First, subjects who underwent both cancer screening and medical examination from 2009 to 2015 and underwent cancer screening once more by 2016 were studied. Data such as the lipid profile and history of smoking obtained during the medical examination, and the grade of atrophy and presence of peptic ulcers were studied using multivariate analysis. Next, subjects who underwent cancer screening twice or more between 2009 and 2015 with or without medical examinations were studied to analyze any correlation between the grade of atrophy and cancer occurrence using univariate analysis. In both studies, the status of Helicobacter pylori (HP) infection was determined.RESULTS:In the multivariate analysis, 9378 subjects were included. Aging, advanced atrophy, presence of ulcers, and uric acid levels were identified as risk factors. Among subjects who underwent successful HP eradication therapy, advanced atrophy and aging were observed to be crucial risk factors. In the univariate analysis, there were 12,941 subjects. Gastric cancer occurred more frequently in the more severe atrophy group (P < 0.001). The annual rate of cancer occurrence in the most severe atrophy group was 0.31%, which was approximately thrice as that in the less atrophy group.CONCLUSIONS:Risk stratification was possible based on endoscopic examination alone. The interval should be set depending on each case. In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings. First, subjects who underwent both cancer screening and medical examination from 2009 to 2015 and underwent cancer screening once more by 2016 were studied. Data such as the lipid profile and history of smoking obtained during the medical examination, and the grade of atrophy and presence of peptic ulcers were studied using multivariate analysis. Next, subjects who underwent cancer screening twice or more between 2009 and 2015 with or without medical examinations were studied to analyze any correlation between the grade of atrophy and cancer occurrence using univariate analysis. In both studies, the status of Helicobacter pylori (HP) infection was determined. In the multivariate analysis, 9378 subjects were included. Aging, advanced atrophy, presence of ulcers, and uric acid levels were identified as risk factors. Among subjects who underwent successful HP eradication therapy, advanced atrophy and aging were observed to be crucial risk factors. In the univariate analysis, there were 12,941 subjects. Gastric cancer occurred more frequently in the more severe atrophy group (P < 0.001). The annual rate of cancer occurrence in the most severe atrophy group was 0.31%, which was approximately thrice as that in the less atrophy group. Risk stratification was possible based on endoscopic examination alone. The interval should be set depending on each case. In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings.OBJECTIVESIn order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings.First, subjects who underwent both cancer screening and medical examination from 2009 to 2015 and underwent cancer screening once more by 2016 were studied. Data such as the lipid profile and history of smoking obtained during the medical examination, and the grade of atrophy and presence of peptic ulcers were studied using multivariate analysis. Next, subjects who underwent cancer screening twice or more between 2009 and 2015 with or without medical examinations were studied to analyze any correlation between the grade of atrophy and cancer occurrence using univariate analysis. In both studies, the status of Helicobacter pylori (HP) infection was determined.METHODSFirst, subjects who underwent both cancer screening and medical examination from 2009 to 2015 and underwent cancer screening once more by 2016 were studied. Data such as the lipid profile and history of smoking obtained during the medical examination, and the grade of atrophy and presence of peptic ulcers were studied using multivariate analysis. Next, subjects who underwent cancer screening twice or more between 2009 and 2015 with or without medical examinations were studied to analyze any correlation between the grade of atrophy and cancer occurrence using univariate analysis. In both studies, the status of Helicobacter pylori (HP) infection was determined.In the multivariate analysis, 9378 subjects were included. Aging, advanced atrophy, presence of ulcers, and uric acid levels were identified as risk factors. Among subjects who underwent successful HP eradication therapy, advanced atrophy and aging were observed to be crucial risk factors. In the univariate analysis, there were 12,941 subjects. Gastric cancer occurred more frequently in the more severe atrophy group (P < 0.001). The annual rate of cancer occurrence in the most severe atrophy group was 0.31%, which was approximately thrice as that in the less atrophy group.RESULTSIn the multivariate analysis, 9378 subjects were included. Aging, advanced atrophy, presence of ulcers, and uric acid levels were identified as risk factors. Among subjects who underwent successful HP eradication therapy, advanced atrophy and aging were observed to be crucial risk factors. In the univariate analysis, there were 12,941 subjects. Gastric cancer occurred more frequently in the more severe atrophy group (P < 0.001). The annual rate of cancer occurrence in the most severe atrophy group was 0.31%, which was approximately thrice as that in the less atrophy group.Risk stratification was possible based on endoscopic examination alone. The interval should be set depending on each case.CONCLUSIONSRisk stratification was possible based on endoscopic examination alone. The interval should be set depending on each case. |
Author | Takeda, Yasuo Ohyama, Shigekazu Uotani, Chika Wakabayashi, Tokio Yamaguchi, Yasushi Yasuda, Kenji Ueno, Toshio Yoneshima, Manabu Hashiba, Atsushi Ninomiya, Itasu Ohno, Kenji Doyama, Hisashi Kaji, Kyosuke Takabatake, Ichiro Kiriyama, Masato Koyama, Nobu |
Author_xml | – sequence: 1 givenname: Kyosuke surname: Kaji fullname: Kaji, Kyosuke – sequence: 2 givenname: Atsushi surname: Hashiba fullname: Hashiba, Atsushi – sequence: 3 givenname: Chika surname: Uotani fullname: Uotani, Chika – sequence: 4 givenname: Yasushi surname: Yamaguchi fullname: Yamaguchi, Yasushi – sequence: 5 givenname: Toshio surname: Ueno fullname: Ueno, Toshio – sequence: 6 givenname: Kenji surname: Ohno fullname: Ohno, Kenji – sequence: 7 givenname: Ichiro surname: Takabatake fullname: Takabatake, Ichiro – sequence: 8 givenname: Tokio surname: Wakabayashi fullname: Wakabayashi, Tokio – sequence: 9 givenname: Hisashi surname: Doyama fullname: Doyama, Hisashi – sequence: 10 givenname: Itasu surname: Ninomiya fullname: Ninomiya, Itasu – sequence: 11 givenname: Masato surname: Kiriyama fullname: Kiriyama, Masato – sequence: 12 givenname: Shigekazu surname: Ohyama fullname: Ohyama, Shigekazu – sequence: 13 givenname: Manabu surname: Yoneshima fullname: Yoneshima, Manabu – sequence: 14 givenname: Nobu surname: Koyama fullname: Koyama, Nobu – sequence: 15 givenname: Yasuo surname: Takeda fullname: Takeda, Yasuo – sequence: 16 givenname: Kenji surname: Yasuda fullname: Yasuda, Kenji |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30315306$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kcFPHCEYxUljU9dt_wAvhsRLL9PywSLM0Wzs1sSkSa1nwjAflXUWVpg5-N-X6aoHDyYEAvm9l4_3TshRTBEJOQX2DZjQ38sKRCsbBrphXLaN_EAWIBWvtxUckQVjjDctV-yYnJSyZQwkV_ITORZMgBTsYkG2m2z7EP_S5OnlmNP-Pji6sWXMYQyF1nVX0E8D9SnT36E80Nsx2zH44OqeIg2RXsU-FZf2VXnrMmKc_Wb-4OPo2kaH-TP56O1Q8MvzuSR3P67-rH82N7821-vLm8bVz4yN4oID73rbes67OqVuNaoONfhOS0Qudc9AodYCW7QdWiaBCwS_UvOLWJKvB999To8TltHsQnE4DDZimorhAG3LL1QNYUnO36DbNOVYpzOCrwSABCkrdfZMTd0Oe7PPYWfzk3lJsQJwAFxOpWT0rwgwMzdlDk2Z2pSZmzKzqXqjcWH8H2nNNwzvKP8BaNSWiQ |
CitedBy_id | crossref_primary_10_1186_s12876_020_01375_z crossref_primary_10_1097_MD_0000000000033942 crossref_primary_10_1111_1751_2980_13193 crossref_primary_10_1159_000538941 crossref_primary_10_1038_s41598_023_47000_3 crossref_primary_10_1080_17474124_2020_1770594 crossref_primary_10_1080_00365521_2022_2089859 crossref_primary_10_1016_j_gie_2019_05_034 crossref_primary_10_1007_s00535_024_02139_2 crossref_primary_10_1111_hel_13056 crossref_primary_10_1016_j_dld_2019_12_146 crossref_primary_10_5009_gnl210313 crossref_primary_10_1007_s10620_020_06813_2 crossref_primary_10_1111_jgh_15396 crossref_primary_10_3390_cancers16122254 crossref_primary_10_1016_j_ebiom_2023_104844 crossref_primary_10_14309_ajg_0000000000000709 crossref_primary_10_3748_wjg_v26_i5_466 crossref_primary_10_1111_den_14118 crossref_primary_10_3390_jcm11123550 crossref_primary_10_3748_wjg_v27_i18_2238 crossref_primary_10_1007_s10120_023_01413_1 crossref_primary_10_1159_000529814 crossref_primary_10_1080_00365521_2020_1740777 crossref_primary_10_5946_ce_2019_072 crossref_primary_10_1111_hel_12669 crossref_primary_10_12998_wjcc_v8_i14_2902 crossref_primary_10_3390_biomedicines10030556 crossref_primary_10_7704_kjhugr_2023_0013 crossref_primary_10_1055_a_1662_5150 crossref_primary_10_1007_s10620_021_07086_z crossref_primary_10_4103_sjg_sjg_206_21 crossref_primary_10_37126_aige_v4_i1_1 crossref_primary_10_3390_cancers16244153 crossref_primary_10_1007_s10388_021_00822_4 crossref_primary_10_1002_jgh3_12360 crossref_primary_10_1007_s00011_021_01501_x crossref_primary_10_1007_s00535_019_01577_7 crossref_primary_10_1016_j_dld_2022_04_025 crossref_primary_10_1080_00365521_2022_2055974 crossref_primary_10_1111_jgh_15693 crossref_primary_10_4253_wjge_v17_i3_99540 crossref_primary_10_1111_jgh_15177 crossref_primary_10_3390_diagnostics11081305 crossref_primary_10_1111_jgh_15282 crossref_primary_10_1080_17474124_2024_2395317 crossref_primary_10_3748_wjg_v29_i31_4763 crossref_primary_10_3748_wjg_v28_i43_6078 crossref_primary_10_3390_ijms26010275 crossref_primary_10_3164_jcbn_20_67 crossref_primary_10_1159_000516561 crossref_primary_10_3390_jcm11154337 crossref_primary_10_3390_jcm13061587 crossref_primary_10_1080_00365521_2023_2220854 crossref_primary_10_7704_kjhugr_2020_0010 |
Cites_doi | 10.1002/ijc.10649 10.1055/s-0028-1098086 10.1016/j.cgh.2014.07.043 10.1002/ijc.22157 10.3748/wjg.v21.i46.13113 10.1016/j.gie.2016.03.791 10.1002/ijc.2910560407 10.1007/s10620-010-1154-0 10.1111/cas.12821 10.1080/003655298750027074 10.1111/j.1349-7006.1995.tb03001.x 10.1111/den.12471 10.1067/mge.2001.114422 10.1111/j.1572-0241.2006.01109.x 10.1007/s00535-006-1924-9 10.1002/ijc.20518 |
ContentType | Journal Article |
Copyright | 2018 by The American College of Gastroenterology |
Copyright_xml | – notice: 2018 by The American College of Gastroenterology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 |
DOI | 10.1038/s41395-018-0259-5 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: ProQuest Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1572-0241 |
EndPage | 79 |
ExternalDocumentID | 30315306 10_1038_s41395_018_0259_5 |
Genre | Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- --K -Q- .55 .GJ 0R~ 123 1B1 1OC 23M 31~ 36B 39C 3O- 4.4 4G. 53G 5RE 5VS 6J9 70F 7X7 88E 8FI 8FJ 8GM AAAAV AAEDT AAGIX AAHPQ AAIQE AAJCS AALRI AAMOA AAQFI AAQKA AAQQT AAQXK AASCR AASXQ AAXUO AAYXX ABASU ABAWZ ABDIG ABJNI ABLJU ABOCM ABPXF ABUWG ABVCZ ABWVN ABXYN ABZZY ACGFO ACGFS ACILI ACKTT ACLDA ACNWC ACOAL ACRPL ACXJB ACXQS ACZKN ADBBV ADFRT ADGGA ADHPY ADKSD ADMUD ADNKB ADNMO ADSXY AEBDS AEETU AENEX AEXYK AFBFQ AFBPY AFDTB AFEBI AFEXH AFFNX AFKRA AFNMH AFUWQ AGAYW AGQPQ AHMBA AHOMT AHQNM AHQVU AHSBF AHVBC AI. AINUH AJAOE AJCLO AJIOK AJNWD AJRNO AJZMW AKCTQ AKRWK AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BENPR BPHCQ BVXVI BYPQX C45 CAG CCPQU CITATION COF CS3 DIWNM EBS EE. EEVPB EJD EMB EMOBN ERAAH F5P FCALG FDB FDQFY FEDTE FGOYB FYUFA GNXGY GQDEL HLJTE HMCUK HVGLF HZ~ IHE IKREB IKYAY IPNFZ JSO LH4 LW6 M1P M41 N4W NQ- O9- ODMTH OPUJH OVD OVDNE P0W P2P PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO R2- RIG RLZ RNT RNTTT ROL RPZ SEW SJN SSZ SV3 TEORI TSPGW UDS UKHRP VH1 X7M XIF XPP ZGI ZXP ZZMQN 3V. AAYOK ACIJW ALIPV CGR CUY CVF ECM EIF NPM SNX 7XB 8FK K9. PKEHL PQEST PQUKI 7X8 |
ID | FETCH-LOGICAL-c395t-723212bda9f22b530898e7be81fb85ee258d017e883e9eabea05123e1f473e9e3 |
IEDL.DBID | 7X7 |
ISSN | 0002-9270 1572-0241 |
IngestDate | Mon Sep 08 11:38:11 EDT 2025 Tue Aug 26 04:12:29 EDT 2025 Wed Feb 19 02:31:36 EST 2025 Thu Apr 24 23:07:17 EDT 2025 Wed Oct 01 06:01:32 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c395t-723212bda9f22b530898e7be81fb85ee258d017e883e9eabea05123e1f473e9e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 30315306 |
PQID | 3243115155 |
PQPubID | 2041977 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2119926730 proquest_journals_3243115155 pubmed_primary_30315306 crossref_primary_10_1038_s41395_018_0259_5 crossref_citationtrail_10_1038_s41395_018_0259_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-01-00 20190101 |
PublicationDateYYYYMMDD | 2019-01-01 |
PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-00 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | The American journal of gastroenterology |
PublicationTitleAlternate | Am J Gastroenterol |
PublicationYear | 2019 |
Publisher | Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins |
Publisher_xml | – name: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins |
References | Lee (R5-20250611) 2015; 13 Hsu (R12-20250611) 2007; 102 Koizumi (R4-20250611) 2004; 112 Shichijo (R13-20250611) 2016; 84 Take (R8-20250611) 2007; 42 Furuta (R10-20250611) 1998; 33 Kimura (R9-20250611) 1969; 3 Kato (R3-20250611) 1990; 50 Sasazuki (R6-20250611) 2002; 101 Sjodahl (R7-20250611) 2007; 120 Sieg (R19-20250611) 2001; 53 Yamamoto (R17-20250611) 2015; 27 Nomura (R16-20250611) 1995; 86 Inoue (R2-20250611) 1994; 56 Kono (R14-20250611) 2015; 21 Mizuno (R15-20250611) 2010; 55 Watanabe (R18-20250611) 2015; 106 30676379 - Am J Gastroenterol. 2019 Apr;114(4):690 30789415 - Am J Gastroenterol. 2019 Apr;114(4):690-691 30844907 - Am J Gastroenterol. 2019 May;114(5):836 |
References_xml | – volume: 101 start-page: 560 year: 2002 ident: R6-20250611 article-title: Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type publication-title: Int J Cancer doi: 10.1002/ijc.10649 – volume: 3 start-page: 87 year: 1969 ident: R9-20250611 article-title: An endoscopic recognition of the atrophic border and its significance in chronic gastritis publication-title: Eodoscopy doi: 10.1055/s-0028-1098086 – volume: 13 start-page: 287 year: 2015 ident: R5-20250611 article-title: A tool to predict risk for gastric cancer in patients with peptic ulcer disease on the basis of a nationwide cohort publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2014.07.043 – volume: 120 start-page: 128 year: 2007 ident: R7-20250611 article-title: Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study publication-title: Int J Cancer doi: 10.1002/ijc.22157 – volume: 21 start-page: 13113 year: 2015 ident: R14-20250611 article-title: Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan publication-title: World J Gastroenterol doi: 10.3748/wjg.v21.i46.13113 – volume: 84 start-page: 618 year: 2016 ident: R13-20250611 article-title: Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication publication-title: Gastrointest Endosc doi: 10.1016/j.gie.2016.03.791 – volume: 56 start-page: 494 year: 1994 ident: R2-20250611 article-title: Life-style and subsite of gastric cancer–joint effect of smoking and drinking habits publication-title: Int J Cancer doi: 10.1002/ijc.2910560407 – volume: 55 start-page: 3132 year: 2010 ident: R15-20250611 article-title: Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis publication-title: Dig Dis Sci doi: 10.1007/s10620-010-1154-0 – volume: 50 start-page: 6559 year: 1990 ident: R3-20250611 article-title: A comparative case-control analysis of stomach cancer and atrophic gastritis publication-title: Cancer Res – volume: 106 start-page: 1738 year: 2015 ident: R18-20250611 article-title: Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population publication-title: Cancer Sci doi: 10.1111/cas.12821 – volume: 33 start-page: 1005 year: 1998 ident: R10-20250611 article-title: Helicobacter pylori infection and progression of gastric atrophy and intestinal metaplasia publication-title: Scand J Gastroenterol doi: 10.1080/003655298750027074 – volume: 86 start-page: 916 year: 1995 ident: R16-20250611 article-title: Gastric cancer among the Japanese in Hawaii publication-title: Jpn J Cancer Res doi: 10.1111/j.1349-7006.1995.tb03001.x – volume: 27 start-page: 551 year: 2015 ident: R17-20250611 article-title: Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings publication-title: Dig Endosc doi: 10.1111/den.12471 – volume: 53 start-page: 620 year: 2001 ident: R19-20250611 article-title: Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists publication-title: Gastrointest Endosc doi: 10.1067/mge.2001.114422 – volume: 102 start-page: 725 year: 2007 ident: R12-20250611 article-title: Helicobacter pylori infection and the risk of gastric malignancy publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2006.01109.x – volume: 42 start-page: 21 issue: Suppl 17 year: 2007 ident: R8-20250611 article-title: Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases publication-title: J Gastroenterol doi: 10.1007/s00535-006-1924-9 – volume: 112 start-page: 1049 year: 2004 ident: R4-20250611 article-title: Cigarette smoking and the risk of gastric cancer: a pooled analysis of two prospective studies in Japan publication-title: Int J Cancer doi: 10.1002/ijc.20518 – reference: 30676379 - Am J Gastroenterol. 2019 Apr;114(4):690 – reference: 30844907 - Am J Gastroenterol. 2019 May;114(5):836 – reference: 30789415 - Am J Gastroenterol. 2019 Apr;114(4):690-691 |
SSID | ssj0015275 |
Score | 2.5180318 |
Snippet | In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification... OBJECTIVES:In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 71 |
SubjectTerms | Adult Aged Cholesterol Committees Endoscopy Female Females Gastric cancer Gastritis, Atrophic - diagnostic imaging Gastritis, Atrophic - epidemiology Gastritis, Atrophic - microbiology Gastritis, Atrophic - pathology Gastroscopy Helicobacter Infections - diagnostic imaging Helicobacter Infections - epidemiology Helicobacter Infections - microbiology Helicobacter Infections - pathology Helicobacter pylori - isolation & purification Hemoglobin Humans Infections Japan - epidemiology Male Medical screening Metabolic syndrome Middle Aged Neoplasm Grading Risk Factors Stomach Neoplasms - diagnostic imaging Stomach Neoplasms - epidemiology Stomach Neoplasms - microbiology Stomach Neoplasms - pathology Ulcers Uric acid |
Title | Grading of Atrophic Gastritis is Useful for Risk Stratification in Endoscopic Screening for Gastric Cancer |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30315306 https://www.proquest.com/docview/3243115155 https://www.proquest.com/docview/2119926730 |
Volume | 114 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1572-0241 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0015275 issn: 0002-9270 databaseCode: AKRWK dateStart: 19980101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-2FsZexr6Xrisa7GkgGtlWLD2NrKQtKy0jW1jehCRLLFuxszj5_3snOx57WMFgsCUZ34fuJ93pDuCDrsaFFyLyYJ3jhbKCW7RDPCCWdU6EiUse_OubyeWi-LKUy37Dre3DKvdzYpqoq8bTHvkpGn5KDIPm79P6D6eqUeRd7UtoPIRDgVCFpLpcDgsuqtgq9_BXZ-Xg1czVaYuTN51NFoqj1ddc_muX_gM2k9E5fwpPerTIph17n8GDUD-HR9e9P_wF_LrYpBh41kQ23W6a9c-VZxe2TRn2W4bXog1xd8sQmrL5qv3NUjZaCg9KHGGrms3qqqGzKdjzm6coHBqP2nfjeHZGgrF5CYvz2fezS95XT-Ae_2zLS8RKInOV1THLnMzHSqtQuqBEdEqGkElVoToGpfKgkVPBon5meRCxKOlJ_goO6qYOb4BZiWrvnNTK60LE6ApbeVFEYUPuMu1GMN7Tzvg-tThVuLg1ycWdK9OR2yC5DZHbyBF8HLqsu7wa9zU-3jPE9CrWmr8CMYL3w2tUDvJ42Do0u9ZQ-jqdTXAWG8HrjpHD13Kqb4ELpqP7B38LjxEj6W7X5RgOtptdeIc4ZOtOkrCdwOH0av7jCu-fZzdf53eTqdyJ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxLMsFDASXJCsru141z4gVJW2W9rtAbrS3oydOGKhSpbNrhB_it_ITF6IA71VyimxJ8r4i-ezZzwD8NpmwyQVIufRh8AT4wX3aId4RC4bgoijUHvwp-ejySz5ONfzLfjdnYWhsMpuTqwn6qxMaY98Dw0_JYZB8_d--YNT1SjyrnYlNBpYnMZfP3HJVr07-YDj-0bKo8OLgwlvqwrwVFm95mPkEEKGzNtcyqDV0FgTxyEakQejY5TaZAjTaIyKFr8gesStVFHkyZjuKJR7A24maphQrv7xvF_gUYVY3dFtK8e9F1WZvQqNBZ2FFoYjy7Bc_2sH_0NuayN3dA_utuyU7Tdwug9bsXgAt6at__0hfDte1TH3rMzZ_npVLr8uUnbsqzqjf8XwmlUx31wypMLs06L6zurstxSOVCOALQp2WGQlnYXBnp9TivohedS-kZOyAwLi6hHMrkWvj2G7KIv4BJjXOM2EoK1JbSLyPCQ-S0WSCx9VkDYMYNjpzqVtKnOqqHHpape6Mq5Rt0N1O1K30wN423dZNnk8rmq82w2Ia3_pyv0F4ABe9Y_xZyQPiy9iuakcpcuzcoSz5gB2moHs36aongYu0J5eLfwl3J5cTM_c2cn56TO4g_zMNjs-u7C9Xm3ic-RA6_CiBh6DL9eN9D92LhYd |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcEG8WChgJLkjWru14Yx8QqtpuW0orBKy0N2MnjlhAybLZCvHX-HXM5IU40FulnBJ7ooy_eD57xjMAL2w-STIhCh59CDwxXnCPdohH5LIhiDgNjQf_7Hx6PE_eLvRiC373Z2EorLKfE5uJOq8y2iMfo-GnxDBo_sZFFxbx_mD2ZvWDUwUp8rT25TRaiJzGXz9x-Va_PjnAsX4p5ezw0_4x7yoM8ExZveEp8gkhQ-5tIWXQamKsiWmIRhTB6BilNjlCNhqjosWviR4xLFUURZLSHYVyr8H1VCWKwsnSxbDYo2qxuqfeVqaDR1WZcY2Gg85FC8ORcViu_7WJ_yG6jcGb3YKbHVNley20bsNWLO_Azlnni78LX4_WTfw9qwq2t1lXqy_LjB35usnuXzO85nVEJTKkxezDsv7Gmky4FJrUoIEtS3ZY5hWdi8GeHzOKACJ51L6Vk7F9AuX6HsyvRK_3YbusyvgQmNc45YSgrclsIooiJD7PRFIIH1WQNoxg0uvOZV1ac6qu8d017nVlXKtuh-p2pG6nR_Bq6LJqc3pc1ni3HxDX_d61-wvGETwfHuOPSd4WX8bqonaUOs_KKc6gI3jQDuTwNkW1NXCx9uhy4c9gBzHu3p2cnz6GG0jVbLv5swvbm_VFfIJ0aBOeNrhj8Pmqgf4Hch8aWA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Grading+of+Atrophic+Gastritis+is+Useful+for+Risk+Stratification+in+Endoscopic+Screening+for+Gastric+Cancer&rft.jtitle=The+American+journal+of+gastroenterology&rft.au=Kaji%2C+Kyosuke&rft.au=Hashiba%2C+Atsushi&rft.au=Uotani%2C+Chika&rft.au=Yamaguchi%2C+Yasushi&rft.date=2019-01-01&rft.issn=1572-0241&rft.eissn=1572-0241&rft.volume=114&rft.issue=1&rft.spage=71&rft_id=info:doi/10.1038%2Fs41395-018-0259-5&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9270&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9270&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9270&client=summon |